Get the Stockscreener App
20.68
8.30%
-1.84
After Hours:
20.68
Kestra Medical Technologies Ltd stock is traded at $20.68, with a volume of 119.69K.
It is down -8.30% in the last 24 hours and down -13.05% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$22.52
Open:
$22.52
24h Volume:
119.69K
Relative Volume:
0.73
Market Cap:
$1.06B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.94%
1M Performance:
-13.05%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$20.64
$22.52
1-Week Range:
$20.70
$23.62
52-Week Range:
$20.00
$26.15
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
20.68 | 1.16B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
553.29 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.36 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.18 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.13 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.55 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Oric Pharmaceuticals (ORIC) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Pfizer (PFE) - The Globe and Mail
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.50 Consensus PT from Analysts - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Optimistic Buy Rating for Kestra Medical Technologies Ltd. Driven by Strategic Expansion and Promising Financial Outlook - TipRanks
Ernst & Young LLP Names Brian Webster of Kestra Medical - GlobeNewswire
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist - The Manila Times
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of ... - Eagle-Tribune
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 7.5%Should You Sell? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kestra Medical Technologies to Participate in Upcoming Investor Conferences - GlobeNewswire
Digital Health Leader Kestra Medical Secures Speaking Slots at Two Major Healthcare Conferences - Stock Titan
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 - GlobeNewswire
Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Target Price at $27.50 - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 - The Manila Times
Kestra Medical Technologies to Showcase Innovation in - GlobeNewswire
Kestra Medical Technologies, Ltd. to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery At Heart Rhythm 2025 - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 12-Month HighShould You Buy? - MarketBeat
The Goldman Sachs Group Has Lowered Expectations for Kestra Medical Technologies (NASDAQ:KMTS) Stock Price - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down Following Weak Earnings - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.3% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Posts Quarterly Earnings Results, Misses Expectations By $0.61 EPS - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss - The AM Reporter
Kestra Medical price target lowered to $23 from $24 at Goldman Sachs - TipRanks
Piper Sandler maintains $27 target on Kestra Medical stock By Investing.com - Investing.com South Africa
Piper Sandler maintains $27 target on Kestra Medical stock - Investing.com Australia
Kestra Medical Technologies revenue jumps 82% to USD 15.1M in Q3 FY25 - Medical Buyer
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 4.3% Following Weak Earnings - Defense World
Kestra Medical Technologies Reports Strong Q3 Growth - TipRanks
Kestra Medical Technologies Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge By Investing.com - Investing.com India
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge - Investing.com Australia
Kestra Medical Tech Reports Third Quarter Fiscal 2025 Financial Results - marketscreener.com
Kestra Medical reports Q3 EPS ($1.25) vs. ($1.18) last year - TipRanks
Earnings Flash (KMTS) Kestra Medical Technologies Posts Q3 Revenue $15.1M, vs. FactSet Est of $15.1M - marketscreener.com
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewswire
Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy - TipRanks
Kestra Medical Technologies, Ltd.'s Quiet Period To End on April 15th (NASDAQ:KMTS) - MarketBeat
Kestra Medical Technologies, Ltd.’s Quiet Period To End on April 15th (NASDAQ:KMTS) - The AM Reporter
Kestra Medical Technologies, Ltd.’s Quiet Period To Expire on April 15th (NASDAQ:KMTS) - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year HighShould You Buy? - MarketBeat
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
There is no financial data for Kestra Medical Technologies Ltd (KMTS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):